NCT06454526 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cummings GG, Tate K, Lee S, Wong CA, Paananen T, Micaroni SPM, Chatterjee GE
Leadership styles and outcome patterns for the nursing workforce and work environment: A systematic review. Int J Nurs Stud. 2018 Sep;85:19-60. doi: 10.1016/j.ijnurstu.2018.04.0
Ghawadra SF, Abdullah KL, Choo WY, Phang CK
Mindfulness-based stress reduction for psychological distress among nurses: A systematic review. J Clin Nurs. 2019 Nov;28(21-22):3747-3758. doi: 10.1111/jocn.14987. Epub 2019 Jul 22.
Janssen M, Heerkens Y, Kuijer W, van der Heijden B, Engels J
Effects of Mindfulness-Based Stress Reduction on employees' mental health: A systematic review. PLoS One. 2018 Jan 24;13(1):e0191332. doi: 10.1371/journal.pone.0191332. eCollection 2018.
Wong CA, Cummings GG, Ducharme L
The relationship between nursing leadership and patient outcomes: a systematic review update. J Nurs Manag. 2013 Jul;21(5):709-24. doi: 10.1111/jonm.12116.

The Mindfulness Level of Manager Nurses, Leadership Behavior, Job Satisfaction, Job Performance, Burnout, Conflict Approach and Intention to Leave Will be Examined as Independent Variables.

Details for clinical trial NCT06454526

Clinical trial NCT06454526 - References